Janney Montgomery Scott Upgrades Danaher (DHR) to Buy
Janney Montgomery Scott upgrades Danaher (NYSE: DHR) from Neutral to Buy. Price target $90.
Analyst, James C. Lucas, says, "Danaher’s shares have underperformed the market this year, while its fundamentals have continued to strengthen. Granted, there are some pockets of the Danaher portfolio that are seeing weakness, but the positives (Product ID, Med Tech, Environmental, and Electronic Test) far outweigh the negatives (Tools and parts of Motion). Danaher is early in its digestion of the acquisition of Tektronix, but the second quarter should see a rebound in organic growth while the underlying company fundamentals remain sound...We have been awaiting a better entry point into this exceptionally well managed organization with strong long-term growth prospects, and it appears the market has given us such an opportunity."
Danaher Corporation (Danaher) derives its sales from the design, manufacture and marketing of professional, medical, industrial and consumer products.
Related Categories
UpgradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
